Courtney Breen
Stock Analyst at Bernstein
(4.50)
# 1,037
Out of 4,478 analysts
289
Total ratings
88.5%
Success rate
20.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Courtney Breen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,300 | $1,200.06 | +8.33% | 57 | Jun 26, 2026 | |
| MRNA Moderna | Rated: Hold | $45 | $81.80 | -44.99% | 40 | Jun 25, 2026 | |
| AMGN Amgen | Maintained: Hold | n/a | $366.44 | - | 29 | Jun 9, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | n/a | $56.70 | - | 30 | Jun 9, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $160 | $129.61 | +23.45% | 29 | Jun 9, 2026 | |
| MRK Merck & Co. | Maintained: Hold | n/a | $126.78 | - | 38 | Jun 9, 2026 | |
| PFE Pfizer | Maintained: Hold | n/a | $23.72 | - | 37 | Jun 9, 2026 | |
| ABBV AbbVie | Maintained: Hold | n/a | $254.76 | - | 28 | Jun 9, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Sell | kr 175.00 | $321.98 | -45.65% | 1 | May 12, 2026 |
Eli Lilly and Company
Jun 26, 2026
Maintained: Buy
Price Target: $1,300
Current: $1,200.06
Upside: +8.33%
Moderna
Jun 25, 2026
Rated: Hold
Price Target: $45
Current: $81.80
Upside: -44.99%
Amgen
Jun 9, 2026
Maintained: Hold
Price Target: n/a
Current: $366.44
Upside: -
Bristol-Myers Squibb Company
Jun 9, 2026
Maintained: Hold
Price Target: n/a
Current: $56.70
Upside: -
Gilead Sciences
Jun 9, 2026
Maintained: Buy
Price Target: $160
Current: $129.61
Upside: +23.45%
Merck & Co.
Jun 9, 2026
Maintained: Hold
Price Target: n/a
Current: $126.78
Upside: -
Pfizer
Jun 9, 2026
Maintained: Hold
Price Target: n/a
Current: $23.72
Upside: -
AbbVie
Jun 9, 2026
Maintained: Hold
Price Target: n/a
Current: $254.76
Upside: -
Novo Nordisk A/S
May 12, 2026
Maintained: Sell
Price Target: kr 175.00
Current: $321.98
Upside: -45.65%